Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Chemidex Pharma Ltd., T/A Essential Generics, Chemidex House, Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, United Kingdom
Doralese Tiltab Tablets 20 mg.
Indoramin 20 mg Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets (tablets). Pale yellow, triangular film-coated tablet, bearing a raised kite shape on each face. |
Each film-coated tablet contains indoramin hydrochloride equivalent to 20 mg of indoramin base.
Excipient with known effect: Each film-coated tablet contains 152 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Indoramin |
Indoramin is an alpha adrenoceptor blocking agent. It acts selectively and competitively on post-synaptic alpha-1 receptors, causing a decrease in peripheral resistance. It also produces relaxation of hyperplastic muscle in the prostate. |
| List of Excipients |
|---|
|
Lactose monohydrate Film-coating: Opadry OY-3736 |
Blister packs – packs of 60.
Chemidex Pharma Ltd., T/A Essential Generics, Chemidex House, Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, United Kingdom
PL 17736/0089
25th February 1998
| Drug | Countries | |
|---|---|---|
| DORALESE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
